KOR
Contact us Privacy Policy

R & D

Developing an innovative new drug platform with the technology for selecting
and producing high-sensitivity and high-efficiency antibodies and the recombinant fusion protein technology

R&D Acivity
  • R&D
  • R&D Acivity
  • Research Planning Team
Research Planning Team Immunodiagnostic Development Team
RESEARCH PLAN
Research Planning Team
The research planning team researches and plans the business performance and product specifications of product research.
01
Business feasibility evaluation for new diagnostic products
To respond to the rapidly changing in vitro diagnostic reagent development technology, we develop new diagnostic technologies and evaluate the business feasibility of these technologies.
02
Securing original technology for new diagnostic technology
To respond to changes in in vitro diagnostic reagent development technology, we are making great efforts to develop source technologies for various diagnostic materials.
Contact us
Head Office : BIO-1 310, 32, Soyanggang-ro, Chuncheon-si, Gangwon State, Republic of Korea
Corporate Research Institute : 2F, 199-9, Dugaebisan-ro, Bukbang-myeon, Hongcheon-gun, Gangwon State, Republic of Korea
  • Tel : 070-4254-4498
  • Fax : 033-258-6416
  • E-mail : sales@hauulbio.com
Contact us